1. Home
  2. IMCC vs CYCN Comparison

IMCC vs CYCN Comparison

Compare IMCC & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • CYCN
  • Stock Information
  • Founded
  • IMCC 1980
  • CYCN 2018
  • Country
  • IMCC Israel
  • CYCN United States
  • Employees
  • IMCC N/A
  • CYCN N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • CYCN Health Care
  • Exchange
  • IMCC Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • IMCC 7.5M
  • CYCN 8.4M
  • IPO Year
  • IMCC N/A
  • CYCN N/A
  • Fundamental
  • Price
  • IMCC $2.25
  • CYCN $3.12
  • Analyst Decision
  • IMCC
  • CYCN
  • Analyst Count
  • IMCC 0
  • CYCN 0
  • Target Price
  • IMCC N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • IMCC 14.3K
  • CYCN 5.8M
  • Earning Date
  • IMCC 03-27-2025
  • CYCN 03-04-2025
  • Dividend Yield
  • IMCC N/A
  • CYCN N/A
  • EPS Growth
  • IMCC N/A
  • CYCN N/A
  • EPS
  • IMCC N/A
  • CYCN N/A
  • Revenue
  • IMCC $38,042,859.00
  • CYCN $194,000.00
  • Revenue This Year
  • IMCC $22.59
  • CYCN N/A
  • Revenue Next Year
  • IMCC $32.86
  • CYCN N/A
  • P/E Ratio
  • IMCC N/A
  • CYCN N/A
  • Revenue Growth
  • IMCC N/A
  • CYCN N/A
  • 52 Week Low
  • IMCC $1.61
  • CYCN $1.27
  • 52 Week High
  • IMCC $8.10
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 48.95
  • CYCN 46.78
  • Support Level
  • IMCC $2.11
  • CYCN $2.81
  • Resistance Level
  • IMCC $2.42
  • CYCN $4.80
  • Average True Range (ATR)
  • IMCC 0.18
  • CYCN 0.76
  • MACD
  • IMCC 0.01
  • CYCN -0.08
  • Stochastic Oscillator
  • IMCC 36.36
  • CYCN 20.76

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: